FR2207698B1 - - Google Patents

Info

Publication number
FR2207698B1
FR2207698B1 FR7341980A FR7341980A FR2207698B1 FR 2207698 B1 FR2207698 B1 FR 2207698B1 FR 7341980 A FR7341980 A FR 7341980A FR 7341980 A FR7341980 A FR 7341980A FR 2207698 B1 FR2207698 B1 FR 2207698B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7341980A
Other languages
French (fr)
Other versions
FR2207698A1 (pt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of FR2207698A1 publication Critical patent/FR2207698A1/fr
Application granted granted Critical
Publication of FR2207698B1 publication Critical patent/FR2207698B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7341980A 1972-11-27 1973-11-26 Expired FR2207698B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30984172A 1972-11-27 1972-11-27

Publications (2)

Publication Number Publication Date
FR2207698A1 FR2207698A1 (pt) 1974-06-21
FR2207698B1 true FR2207698B1 (pt) 1976-09-03

Family

ID=23199896

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7341980A Expired FR2207698B1 (pt) 1972-11-27 1973-11-26

Country Status (16)

Country Link
JP (1) JPS5843371B2 (pt)
AT (1) AT325208B (pt)
AU (1) AU6265873A (pt)
BE (1) BE807527A (pt)
CA (1) CA1016069A (pt)
DE (1) DE2357800A1 (pt)
DK (1) DK135270B (pt)
ES (1) ES420846A1 (pt)
FR (1) FR2207698B1 (pt)
GB (1) GB1435816A (pt)
IL (1) IL43643A (pt)
IT (1) IT1196391B (pt)
NL (1) NL7315859A (pt)
NO (1) NO137861C (pt)
SE (1) SE390795B (pt)
ZA (1) ZA738779B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
US4057628A (en) * 1976-04-19 1977-11-08 William L. Wilson Removal of hepatitis associated antigen from plasma
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
JPS5347515A (en) * 1976-10-13 1978-04-28 Green Cross Corp:The Gamma-globulin pharmaceutical preparation for intravenous injection
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
JPS5732228A (en) * 1980-08-05 1982-02-20 Green Cross Corp:The Preparation of immunoglobulin usable for intravenous injection
ATE17654T1 (de) * 1981-10-29 1986-02-15 Green Cross Corp Verfahren zur herstellung von intravenoesem injizierbarem immunoglobulin.
JPS58180433A (ja) * 1982-04-16 1983-10-21 Fujirebio Inc 免疫グロブリンから抗補体作用物質の除去法

Also Published As

Publication number Publication date
NO137861C (no) 1978-05-10
AU6265873A (en) 1975-05-22
FR2207698A1 (pt) 1974-06-21
ES420846A1 (es) 1976-06-16
AT325208B (de) 1975-10-10
DK135270C (pt) 1977-09-19
NL7315859A (pt) 1974-05-29
GB1435816A (en) 1976-05-19
IL43643A (en) 1976-10-31
BE807527A (fr) 1974-03-15
CA1016069A (en) 1977-08-23
JPS4981519A (pt) 1974-08-06
DK135270B (da) 1977-03-28
DE2357800A1 (de) 1974-06-06
ZA738779B (en) 1974-10-30
IL43643A0 (en) 1974-03-14
IT1196391B (it) 1988-11-16
SE390795B (sv) 1977-01-24
JPS5843371B2 (ja) 1983-09-27
NO137861B (no) 1978-03-30

Similar Documents

Publication Publication Date Title
FR2207698B1 (pt)
CH574065A5 (pt)
BG19658A1 (pt)
BG18254A1 (pt)
BG18294A1 (pt)
BG18360A1 (pt)
CH574189A5 (pt)
BG19971A1 (pt)
BG22845A3 (pt)
CH171873A4 (pt)
CH553445A (pt)
CH575177A5 (pt)
CH559458A5 (pt)
CH559529A5 (pt)
CH559570A5 (pt)
CH560134A5 (pt)
CH560717A5 (pt)
CH561632A5 (pt)
CH561861A5 (pt)
CH562136A5 (pt)
CH562161A5 (pt)
CH564104A5 (pt)
CH565479A5 (pt)
CH565527A5 (pt)
CH567667A5 (pt)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse